|Bid||5.94 x 21500|
|Ask||5.97 x 4000|
|Day's range||5.94 - 6.40|
|52-week range||5.94 - 67.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Tilray Brands (NASDAQ: TLRY) reported its latest quarterly results last week. Using three charts, I'll look at just what drove those improved numbers and whether Tilray had a good quarter or not, and determine if it looks to be a better buy right now. In the company's second-quarter results, for the period ending Nov. 30, 2021, Tilray reported net revenue of $155.2 million.
Tilray CEO Irwin Simon joins Yahoo Finance Live’s Julie Hyman to discuss the cannabis industry, why the company is pivoting to food and beverage brands, weed legalization in the U.S., and the end of a partnership with Budweiser.
Cannabis stocks and ETFs were massively downbeat in 2021. However, strong sales backdrop, growing medical usage and still-alive chances of a federal approval may cause a bounce back in pot ETFs in 2022.